Feb. 25 (Bloomberg) -- "Capitol Gains" takes a look at the federal government's crackdown on American companies bribing their way to big business overseas. Peter Cook talks to Bloomberg Government analyst Sandy Reback about his new study documenting the increased enforcement of the Foreign Corrupt Practices Act.
17:40 - Martin Shkreli, whose purchase last week of a majority stake in KaloBios Pharmaceuticals Inc. generated pain for anyone betting against the stock, had more news for short sellers Friday: he’ll stop making his shares available to borrow. Bloomberg's Tracy Alloway reports on "Bloomberg Markets." (Source: Bloomberg)
Does the ECB Have to Act So Aggressively?
Sales Check With Hudson's Bay CEO Jerry Storch
Black Friday Retail Sales: The Winners & the Losers
Please upgrade your Browser
Your browser is out-of-date. Please download one of these excellent browsers: